Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction
Hiroshi Nishi, T Higashihara, Reiko Inagi
Nutrients (2019) Vol. 11, Iss. 7, pp. 1664-1664
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Lucas Opazo-Ríos, Sebastián Mas, Gema Marín‐Royo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2632-2632
Open Access | Times Cited: 244
Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Omar Emiliano Aparicio‐Trejo, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1144-1144
Open Access | Times Cited: 134
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Jingyue Wang, Quanwei Wang, Xinyu Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 121
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e320-e350
Open Access | Times Cited: 25
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Obesity Pillars (2024) Vol. 10, pp. 100108-100108
Open Access | Times Cited: 19
Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease
Kentaro Yoshioka, Yosuke Hirakawa, Makoto Kurano, et al.
Kidney International (2021) Vol. 101, Iss. 3, pp. 510-526
Open Access | Times Cited: 76
Roles and crosstalks of macrophages in diabetic nephropathy
Hai-Di Li, Yong‐Ke You, Baoyi Shao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 61
Kidney Damage Caused by Obesity and Its Feasible Treatment Drugs
Meihui Wang, Zixu Wang, Yaoxing Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 747-747
Open Access | Times Cited: 52
Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis
Limin Liu, Xiaoxuan Ning, Wei Lei, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3758-3775
Open Access | Times Cited: 42
Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders
Wen Han, Shuxian Yang, Haiyan Xiao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15627-15627
Open Access | Times Cited: 41
White Adipose Tissue Dysfunction: Pathophysiology and Emergent Measurements
Natalia Santillana, Camila Astudillo-Guerrero, Amanda D’Espessailles, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1722-1722
Open Access | Times Cited: 31
DiDang decoction improves mitochondrial function and lipid metabolism via the HIF-1 signaling pathway to treat atherosclerosis and hyperlipidemia
Xize Wu, Jiaxiang Pan, JJ Jiajia Yu, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116289-116289
Closed Access | Times Cited: 28
Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 183-183
Open Access | Times Cited: 25
Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus
Saisai Huang, Zhuoya Zhang, Yiyuan Cui, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 6, pp. 1565-1572
Open Access | Times Cited: 25
Supplementation with aspalathin and sulforaphane protects cultured cardiac cells against dyslipidemia-associated oxidative damage
Sinenhlanhla X. H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Sonia Silvestri, et al.
Metabolism Open (2025) Vol. 25, pp. 100346-100346
Open Access | Times Cited: 1
Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM)
Yayu Fang, Wei Liu, Xiaoling Cai, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach
Hiroshi Nishi, Koji Takemura, T Higashihara, et al.
Nutrients (2020) Vol. 12, Iss. 6, pp. 1814-1814
Open Access | Times Cited: 52
Mitochondrial Dysfunction in Kidney Disease and Uremic Sarcopenia
Koji Takemura, Hiroshi Nishi, Reiko Inagi
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 50
Mitochondrial dysfunction and endoplasmic reticulum stress in the promotion of fibrosis in obstructive nephropathy induced by unilateral ureteral obstruction
Elena Martínez‐Klimova, Omar Emiliano Aparicio‐Trejo, Tania Gómez‐Sierra, et al.
BioFactors (2020) Vol. 46, Iss. 5, pp. 716-733
Closed Access | Times Cited: 50
Metabolic Changes and Oxidative Stress in Diabetic Kidney Disease
Midori Sakashita, Tetsuhiro Tanaka, Reiko Inagi
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1143-1143
Open Access | Times Cited: 46
New Pandemic: Obesity and Associated Nephropathy
Isha Sharma, Yingjun Liao, Xiaoping Zheng, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 42
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
Habib Yaribeygi, Mina Maleki, Željko Reiner, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6544-6544
Open Access | Times Cited: 28
Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA/p47PHOX mediated ferroptosis
Xinzhu Ni, Lian Duan, Yandong Bao, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Elucidating ascorbate and aldarate metabolism pathway characteristics via integration of untargeted metabolomics and transcriptomics of the kidney of high-fat diet-fed obese mice
Hong Liang, Kang Song
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0300705-e0300705
Open Access | Times Cited: 6
Bridging lipid metabolism and mitochondrial genome maintenance
C W Boone, Samantha C. Lewis
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107498-107498
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top